The European Medicines Agency (EMA) on 19 November issued advice to member states on how to use Merck Sharp & Dohme’s and Ridgeback Biotherapeutics’ antiviral drug Lagevrio (molnupiravir), an oral ...
The European Medicines Agency (EMA) is gathering oncology experts to discuss the use of data from single-arm clinical trials to support filings for regulatory approvals of cancer drugs. EMA wants to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results